| Primary |
| Intentional Overdose |
30.0% |
| Abdominal Pain Upper |
20.0% |
| Anxiety |
10.0% |
| Cystitis |
10.0% |
| Diuretic Therapy |
10.0% |
| Hypertension |
10.0% |
| Insomnia |
10.0% |
|
| Rash |
33.3% |
| Sopor |
33.3% |
| Vomiting |
33.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
20.0% |
| Intentional Overdose |
15.0% |
| Polyarthritis |
15.0% |
| Dyspepsia |
10.0% |
| Rheumatoid Arthritis |
10.0% |
| Abdominal Pain Upper |
5.0% |
| Anxiety |
5.0% |
| Cystitis |
5.0% |
| Diuretic Therapy |
5.0% |
| Hypertension |
5.0% |
| Insomnia |
5.0% |
|
| Rhabdomyolysis |
28.6% |
| Gastric Ulcer |
14.3% |
| Self Injurious Behaviour |
14.3% |
| Tachycardia |
14.3% |
| Urticaria Papular |
14.3% |
| Vomiting |
14.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.5% |
| Drug Use For Unknown Indication |
19.3% |
| Hypertension |
11.9% |
| Rheumatoid Arthritis |
6.3% |
| Breast Cancer |
5.3% |
| Prophylaxis |
3.2% |
| Non-small Cell Lung Cancer |
2.4% |
| Diabetes Mellitus |
2.3% |
| Plasma Cell Myeloma |
2.0% |
| Hepatic Cirrhosis |
1.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.9% |
| Thrombosis Prophylaxis |
1.6% |
| Thyroid Cancer |
1.5% |
| Bone Pain |
1.3% |
| Premedication |
1.3% |
| Depression |
1.2% |
| Hepatocellular Carcinoma |
1.1% |
| Metastatic Renal Cell Carcinoma |
1.1% |
| Acute Myeloid Leukaemia |
1.0% |
| Atrial Fibrillation |
1.0% |
|
| Syncope |
17.1% |
| Death |
8.9% |
| Osteonecrosis |
6.8% |
| Sopor |
6.8% |
| Vomiting |
6.8% |
| Neutropenia |
5.5% |
| Presyncope |
4.8% |
| Renal Failure Acute |
4.8% |
| Pyrexia |
4.1% |
| Skin Lesion |
4.1% |
| Epilepsy |
3.4% |
| Hemiparesis |
3.4% |
| Rectal Haemorrhage |
3.4% |
| Somnolence |
3.4% |
| Haemoptysis |
2.7% |
| Hepatitis Acute |
2.7% |
| Loss Of Consciousness |
2.7% |
| Myelodysplastic Syndrome |
2.7% |
| Pruritus |
2.7% |
| Pseudomonal Sepsis |
2.7% |
|
